Document is current

Article History

Received: 6 April 2021

Accepted: 2 August 2021

First Online: 22 August 2021

Declarations

:

: All patients signed a informed consent ant the protocol was approved by local Ethical's Comittee.

: All patients gave consent for publication.

: Electronic medical records from our centre.

: Martínez Vila C. and Aya Moreno F have received travel grants and other honoraria from BMS, MSD, Novartis and Roche. Teixido C., has received personal fees from Pfizer, Novartis, MSD, Roche, AstraZeneca and Takeda, and research funding from Novartis. Arance Fernandez A.M. discloses travel grants, speaking fees and paid consulting from BMS, Roche, Novartis, Pierre-Fabre, Merck Serono, Sanofi and MSD. None were declared for the remaining authors.

: Aya Moreno F, is a recipient of a PhD for Medical Doctors Program Fellowship and a grant from the Spanish Multidisciplinary Melanoma Group (GEM). Malvehy J., grants to his institution from Leo Pharma, Almirall, Castle Bioscience, AMLO Bioscience, Melagenics, Amgen, Roche-Posay ; Consultancy fees from Almirall, Amgen, Leo Pharma, Isdin, Sunpharma, Roche, Pierre Fabre; Speaker bureau from La Roche Posay, Roche, Pierre Fabre, BMS, Bioderma, Sanofi, ISDIN, Sunpharma.

: Manuscript writing: Martínez Vila C., Arance Fernandez A.M. Manuscript editing: Martinez Vila, C., Aya Moreno F., Mugica Estébanez M., Ruiz G., Villacampa G., Dashti P., Oberoi H. S., Martin-Huertas R., Jares P., Alos L., Teixido C., Rull R., Sanchez M., Malvehy J., Carcelero E., Valduvieco I., Arance Fernandez A.. Collecting data: Martinez Vila, C., Aya Moreno F., Mugica Estébanez M., Ruiz G., Villacampa G., Dashti P., Oberoi H. S., Martin-Huertas R., Jares P., Alos L., Teixido C., Rull R., Sanchez M., Malvehy J., Carcelero E., Valduvieco I., Arance Fernandez A.

: To the patients and their families.